Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Conclusion: Bone markers in metastatic bone disease.

Robert E Coleman1

  • 1Cancer Research Centre,Academic Unit of Clinical Oncology, Broomcross Building, Weston Park Hospital, Sheffield S10 2SJ, UK. r.e.coleman@sheffield.ac.uk

Cancer Treatment Reviews
|May 9, 2006
PubMed
Summary

Biochemical markers of bone turnover are increasingly used for diagnosing and monitoring bone metastases (MBD). Research is validating these markers for assessing bone resorption and formation in MBD patients.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Caffeic Acid, Reduced Glutathione, and Ferric Iron Addition Effects on the Redox Potential of Model Wine Solutions.

Molecules (Basel, Switzerland)·2026
Same author

Controlling the redox potential in red wines through cap management and mixing techniques.

Food chemistry·2025
Same author

Effect of Contrasting Redox Potential Evolutions and Cap Management Techniques on the Chemical Composition of Red Wine.

Molecules (Basel, Switzerland)·2025
Same author

Breast Cancer Index in Premenopausal Women With Early-Stage Hormone Receptor-Positive Breast Cancer.

JAMA oncology·2024
Same author

Radium-223 in women with hormone receptor-positive bone-metastatic breast cancer receiving endocrine therapy: pooled analysis of two international, phase 2, randomized, double-blind, placebo-controlled trials.

Breast cancer research and treatment·2023
Same author

Chain Reaction of Fenton Autoxidation of Tartaric Acid: Critical Behavior at Low pH.

The journal of physical chemistry. B·2023

Area of Science:

  • Oncology
  • Biochemistry
  • Orthopedics

Background:

  • Bone metastases are common in multiple myeloma and breast, prostate, and lung cancers.
  • Metastatic bone disease (MBD) is linked to abnormal bone remodeling.
  • Elevated biochemical markers of bone turnover are found in MBD patients.

Purpose of the Study:

  • To review and summarize research on biochemical markers for bone resorption and formation in MBD.
  • To assess the diagnostic and follow-up potential of bone turnover markers in MBD.

Main Methods:

  • Literature review of leading studies on bone markers in MBD.
  • Analysis of data relating to markers of bone resorption and formation.

Main Results:

Related Experiment Videos

  • Biochemical markers of bone turnover show promise in MBD diagnosis and monitoring.
  • Validation studies support the use of these markers.

    • Conclusions:

    • Bone turnover markers are valuable tools for managing MBD.
    • Further research confirms their utility in assessing bone resorption and formation in MBD.